ABCL: AbCellera Biologics Kompaniya qiymatining sof foydaga nisbati
IT va biologiya chorrahasidagi noyob mutaxassislarni saqlab qolish AbCellera Biologics (ABCL) rivojlanishini barqarorlashtiradi. P/E ga asoslangan biznes baholash narx dinamikasini namoyish etadi, bunda -25.10 ko'rsatkichi ushbu darajani belgilaydi. O'sish bulutli AI asosidagi antitanalar kashfiyoti va hamkorlik royaltilari hisobiga ta'minlanmoqda. Shu bilan birga, yuqori texnologiyali laboratoriyalar va grantlar yetakchi olimlarning sodiqligini ta'minlab, kengayish uchun ishonchli poydevor yaratadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_ABCL_-_AbCellera-Biologics_-_PE-Multiple "ABCL: AbCellera Biologics Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
AbCellera Biologics (ABCL) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati abcellera.com|ABCL - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati AbCellera Biologics Inc.|ABCL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz AbCellera|Tezkor likvidlik koeffitsiyenti abcellera.com
- foyda va bozor multiplikatorlari tafsilotlari:
ABCL - Sof foyda|Kutilayotgan foyda AbCellera Biologics|ABCL - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati AbCellera Biologics Inc|ABCL - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati AbCellera Biologics Inc.|ABCL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda AbCellera|ABCL - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi abcellera.com|ABCL - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi AbCellera Biologics
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:AbCellera Biologics Inc. ABCL
AbCellera Biologics (ABCL) uchun narx-foyda koeffitsiyenti FDA ning qat'iy nazorati sharoitida kompaniyaning AI platformasi va patent portfelining monetizatsiyasiga oid bozor kutuvlarini aks ettiradi. Kompaniyaga tegishli P/E koeffitsiyenti o'zgarishlarini tahlil qilish orqali investorlar aktiv uchun to'langan premiumni baholashi, shuningdek, joriy kapitalizatsiyaning haqiqiy biznes daromadlari va raqobatchilarga nisbatan texnologik ustunligi bilan qanchalik asoslanganligini aniqlashi mumkin.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN - P/E multiplikatori|PHAR: P/E multiplikatori|NKTR (nektar.com) - Narxning foydaga nisbati|UPB (Upstream Bio) - P/E multiplikatori|Narx-foyda koeffitsiyenti Zenas Bio (ZBIO)|P/E multiplikatori IMNM|GOSS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati KalVista Pharmaceuticals KALV|septerna.com - Narxning foydaga nisbati|PVLA - Narxning foydaga nisbati|SVRA: Narxning foydaga nisbati|RIGL: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati AnaptysBio Inc. (ANAB)|Narxning foydaga nisbati Astria Therapeutics|ENGN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RAPT|P/E multiplikatori aerovatetx.com (JBIO)|Aclaris - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Avalo Therapeutics Inc.|Kapitalizatsiyaning foydaga nisbati Eledon Pharmaceuticals, Inc ELDN|Narxning foydaga nisbati Agenus (AGEN)|Narxning foydaga nisbati CLYM (climbbio.com)|Narxning foydaga nisbati Zura Bio ZURA|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning foydaga nisbati|Adagene Corp - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti ImageneBio Inc (IMA)|STTK: P/E multiplikatori|EQ - Biznesning o‘zini qoplash muddati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Narx-foyda koeffitsiyenti Immunic Inc (IMUX)|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Biznesning o‘zini qoplash muddati inflarx.de|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|Celularity Corp - P/E multiplikatori|INMB: Narxning foydaga nisbati|BRNS: P/E multiplikatori|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|Narxning foydaga nisbati SAB Biotherapeutics|Narxning foydaga nisbati AKTX|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|QTTB: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Kompaniya qiymatining sof foydaga nisbati EDSA|iBio, Inc. - P/E multiplikatori|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|GRI Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|THRD: P/E multiplikatori
